Alterola Biotech (OTCMKTS:ALTA) Releases Quarterly Earnings Results, Beats Expectations By $0.08 EPS
Alterola Biotech (OTCMKTS:ALTA) released its quarterly earnings data on Wednesday. The company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.08, Fidelity Earnings reports.
Shares of Alterola Biotech stock traded down $0.32 during midday trading on Thursday, hitting $20.20. The company’s stock had a trading volume of 4,132 shares, compared to its average volume of 40,469. The company’s 50-day simple moving average is $11.91. Alterola Biotech has a 1-year low of $13.55 and a 1-year high of $31.27.
In related news, Director Jr. Fred W. Fairclough sold 3,750 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $23.23, for a total transaction of $87,112.50. Also, major shareholder Russell Gunther sold 1,600 shares of the stock in a transaction on Monday, July 13th. The stock was sold at an average price of $20.75, for a total value of $33,200.00. Following the sale, the insider now owns 70,724 shares of the company’s stock, valued at $1,467,523. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,605 shares of company stock valued at $371,780.
Alterola Biotech, Inc, a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Its products under development include appetite suppressors, cholesterol suppressors, antioxidant gums, motion sickness suppressors, and vitamin gums.
Receive News & Ratings for Alterola Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alterola Biotech and related companies with MarketBeat.com's FREE daily email newsletter.